Eurofins Scientific Financials
| ERF Stock | EUR 47.41 0.45 0.96% |
Eurofins |
Understanding current and past Eurofins Scientific Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Eurofins Scientific's financial statements are interrelated, with each one affecting the others. For example, an increase in Eurofins Scientific's assets may result in an increase in income on the income statement.
Please note, the presentation of Eurofins Scientific's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Eurofins Scientific's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Eurofins Scientific's management manipulating its earnings.
Eurofins Scientific Stock Summary
Eurofins Scientific competes with Sartorius Stedim, Teleperformance, Biomerieux, Dassault Systemes, and Worldline. Eurofins Scientific SE, through its subsidiaries, provides various analytical testing services worldwide. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg. EUROFINS SCIENT operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. It employs 43819 people.| Foreign Associate | USA |
| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0014000MR3 |
| Business Address | 23 Val Fleuri, |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Benchmark | Dow Jones Industrial |
| Website | www.eurofins.com |
| Phone | 352 26 18 53 20 |
| Currency | EUR - Euro |
You should never invest in Eurofins Scientific without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Eurofins Stock, because this is throwing your money away. Analyzing the key information contained in Eurofins Scientific's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Eurofins Scientific Key Financial Ratios
Eurofins Scientific's financial ratios allow both analysts and investors to convert raw data from Eurofins Scientific's financial statements into concise, actionable information that can be used to evaluate the performance of Eurofins Scientific over time and compare it to other companies across industries.| Return On Equity | 0.15 | |||
| Return On Asset | 0.075 | |||
| Target Price | 76.2 | |||
| Beta | 0.63 | |||
| Z Score | 3.6 |
Eurofins Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Eurofins Scientific's current stock value. Our valuation model uses many indicators to compare Eurofins Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eurofins Scientific competition to find correlations between indicators driving Eurofins Scientific's intrinsic value. More Info.Eurofins Scientific SE is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.49 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Eurofins Scientific SE is roughly 2.03 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Eurofins Scientific by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Eurofins Scientific's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Eurofins Scientific Systematic Risk
Eurofins Scientific's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Eurofins Scientific volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Eurofins Scientific correlated with the market. If Beta is less than 0 Eurofins Scientific generally moves in the opposite direction as compared to the market. If Eurofins Scientific Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Eurofins Scientific is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Eurofins Scientific is generally in the same direction as the market. If Beta > 1 Eurofins Scientific moves generally in the same direction as, but more than the movement of the benchmark.
Eurofins Scientific November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Eurofins Scientific help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Eurofins Scientific SE. We use our internally-developed statistical techniques to arrive at the intrinsic value of Eurofins Scientific SE based on widely used predictive technical indicators. In general, we focus on analyzing Eurofins Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Eurofins Scientific's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 16.03 | |||
| Value At Risk | (3.19) | |||
| Potential Upside | 2.4 |
Complementary Tools for Eurofins Stock analysis
When running Eurofins Scientific's price analysis, check to measure Eurofins Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurofins Scientific is operating at the current time. Most of Eurofins Scientific's value examination focuses on studying past and present price action to predict the probability of Eurofins Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurofins Scientific's price. Additionally, you may evaluate how the addition of Eurofins Scientific to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |